Search Results 141-150 of 17306 for egfr

1. Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) - Mayo Clinic

   Participation eligibility · Previously registered to A151216, with the result of lung cancer harboring an EGFR exon 19 deletion or L858R mutation; the testing ...

2. Evaluating A Mobile Health Monitoring Platform For Capturing Patient-centered Outcomes Among Heart Failure Patients - Mayo Clinic

   ... (eGFR) < 20 mL/min/1.73 m2 or receiving dialysis at screening. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

3. A Study to Evaluate Fertility, Sexual Function, and Endothelial Health in Premenopausal Women with Kidney Disease - Mayo Clinic

   Currently being evaluated for kidney transplant (eGFR < 20ml/min). Exclusion Criteria (Aim 1 & 2): Women who are currently pregnant. Prior history of ...

4. Study Of Cabozantinib Alone Or In Combination With Atezolizumab To Subjects With Locally Advanced Or Metastatic Solid Tumors - Mayo Clinic

   Allowed are up to 2 lines of prior systemic anticancer therapy for inoperable locally advanced, recurrent, or metastatic disease. Prior EGFR-targeted therapy ...

5. Stage 4 Prostate Cancer Clinical Trials - Mayo Clinic Research

   ... (eGFR ≥ 60ml/min). Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy In Black Men With Locally Advanced, Biochemically Recurrent And ...

6. Bispecific antibody therapy - Mayo Clinic

   Solid tumors. Amivantamab (Rybrevant) attaches to EGFR and MET proteins to treat certain types of non-small cell lung cancer. Tarlatamab (Imdelltra) ...

7. DIAGNOSTIC IMAGING REFERRAL FORM - Mayo Clinic

   eGfr and date. NB: If Yes to any of the details please inform the Imaging Department prior to the examination. REFERRING CLINICIAN DETAILS –IR(ME)R 2017 ...

8. Study Of DS-1062a In Advanced Or Metastatic Non-small Cell Lung Cancer With Actionable Genomic Alterations (TROPION-Lung05) - Mayo Clinic

   ... EGFR, ALK, ROS1, NTRK, BRAF, MET exon 14 skipping, and RET) and that has progressed on or after 1 or more kinase inhibitors and platinum-based chemotherapy.

9. A Study to Evaluate How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease - Mayo Clinic

   serum creatinine-based eGFR greater than or equal to 25 and less than 50 mL/min/1.73 m^2 (CKD-EPI) and UACR greater than 100 and less than 5000 mg/g. Treatment ...

10. Nedosiran In Pediatric Patients From Birth To 5 Years Of Age With PH And Relatively Intact Renal Function - Mayo Clinic

    ... eGFR and serum creatinine. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or ...